- Home
- AUTL vs HPF Comparison
AUTL vs HPF Comparison
Compare AUTL & HPF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AUTL
- HPF
- Stock Information
- Founded
- AUTL 2014
- HPF 2002
- Country
- AUTL United Kingdom
- HPF United States
- Employees
- AUTL N/A
- HPF N/A
- Industry
- AUTL Biotechnology: Biological Products (No Diagnostic Substances)
- HPF Finance Companies
- Sector
- AUTL Health Care
- HPF Finance
- Exchange
- AUTL Nasdaq
- HPF Nasdaq
- Market Cap
- AUTL 359.3M
- HPF 325.2M
- IPO Year
- AUTL 2018
- HPF N/A
- Fundamental
- Price
- AUTL $1.27
- HPF $16.20
- Analyst Decision
- AUTL Strong Buy
- HPF
- Analyst Count
- AUTL 5
- HPF 0
- Target Price
- AUTL $9.32
- HPF N/A
- AVG Volume (30 Days)
- AUTL 2.4M
- HPF 35.3K
- Earning Date
- AUTL 05-08-2025
- HPF 01-01-0001
- Dividend Yield
- AUTL N/A
- HPF 8.96%
- EPS Growth
- AUTL N/A
- HPF N/A
- EPS
- AUTL N/A
- HPF N/A
- Revenue
- AUTL $9,011,000.00
- HPF N/A
- Revenue This Year
- AUTL $277.74
- HPF N/A
- Revenue Next Year
- AUTL $221.89
- HPF N/A
- P/E Ratio
- AUTL N/A
- HPF N/A
- Revenue Growth
- AUTL N/A
- HPF N/A
- 52 Week Low
- AUTL $1.11
- HPF $12.99
- 52 Week High
- AUTL $5.00
- HPF $16.80
- Technical
- Relative Strength Index (RSI)
- AUTL 43.50
- HPF 57.61
- Support Level
- AUTL $1.15
- HPF $15.75
- Resistance Level
- AUTL $1.44
- HPF $16.41
- Average True Range (ATR)
- AUTL 0.13
- HPF 0.21
- MACD
- AUTL 0.01
- HPF 0.08
- Stochastic Oscillator
- AUTL 29.27
- HPF 57.14
About AUTL Autolus Therapeutics plc
Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7 & AUTO8.
About HPF John Hancock Pfd Income Fund II Pfd Income Fund II
John Hancock Preferred Income Fund II is the United States based closed-end, diversified management investment company. Its primary objective is to provide a high level of current income consistent with preservation of capital. The fund's secondary investment objective is to provide growth of capital to the extent consistent with its primary investment objective. The fund's principal investment strategies include to invests a majority of its assets in preferred stocks and other preferred securities, including convertible preferred securities. Its portfolio composition consists of U.S preferred securities, common stocks, foreign preferred securities, corporate bonds, capital preferred securities and short-term investments.